← Back to Search

Health Program for Breast Cancer Survivors

N/A

Recruiting

Led By Alexis Beatty, MD, MAS

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18+

Treated with curative intent

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial studies a multi-disciplinary health program to help breast cancer survivors at SF General Hospital. #breastcancer

Who is the study for?

This trial is for breast cancer survivors over 18 who can communicate in English, Spanish, or Cantonese. Participants must have been treated with the intent to cure at Zuckerberg San Francisco General Hospital and not be planning further chemotherapy, radiation, or surgery within the next three months.Check my eligibility

What is being tested?

The HEART-ACT study tests a health behavior intervention for breast cancer survivors. It includes an intake session followed by individual and group sessions focused on exercise and lifestyle changes, concluding with a graduation.See study design

What are the potential side effects?

Since this trial focuses on behavioral interventions like exercise rather than medication, side effects are minimal but may include typical exercise-related discomforts such as muscle soreness.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

My treatment was aimed at curing my condition.

Select...

I have been diagnosed with breast cancer.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Proportion of participants with analyzable data for change in 6 Minute Walk Distance (6MWD)

Proportion of participants with analyzable data for change in PROMIS Global Health - Physical Health Scale

Proportion of participants with analyzable data for change in Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health - Mental Scale

Secondary outcome measures

Change in 6MWD

Change in PROMIS Global Health - Mental Scale

Change in PROMIS Global Health - Physical Scale

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Health Behavior ProgramExperimental Treatment5 Interventions

Each participant will have an individualized assessment with plan and goals set at the program intake visit. Program components will include: Physical Activity, Nutrition, Emotional Well-being, Cardiovascular Risk, Survivorship, and other items individualized to the participant as needed (e.g., tobacco cessation). The 12-week program will alternate between group and individual sessions each week. Individualized plans will be reviewed every two weeks at the participant individual sessions.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Exercise

2016

Completed Phase 1

~760

Group Sessions

2008

N/A

~160

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor

2,507 Previous Clinical Trials

15,238,525 Total Patients Enrolled

45 Trials studying Breast Cancer

3,828,385 Patients Enrolled for Breast Cancer

Alexis Beatty, MD, MASPrincipal InvestigatorUniversity of California, San Francisco

2 Previous Clinical Trials

554 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any open enrollment spots available for this experiment?

"According to information hosted on clinicaltrials.gov, this medical study is not actively seeking participants at the present moment. It was first posted online in December of 2023 and had its last update in September of the same year. Despite this, there are still over 2700 other studies recruiting patients now."

Answered by AI

What key aims does this investigation seek to achieve?

"This clinical trial will evaluate, over a 12 month duration beginning at baseline, the proportion of participants with assessable data concerning the change in Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health - Mental Scale. Secondary objectives encompass assessing changes in 6MWD generated after six minutes of walking; PROMIS Global Health - Mental Scale and PROMIS Global Health - Physical scale from start to three months respectively."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Heart Health After Cancer Treatment (HEART-ACT)

2023. "Heart Health After Cancer Treatment (HEART-ACT)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06055803.